Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

dornase alfa inhalation solution

(DOR-nays AL-fuh in-huh-LAY-shun suh-LOO-shun)
A drug given in an aerosol mist to decrease the thickness of mucus in the lungs of patients with cystic fibrosis. It is also being studied as a treatment to reduce the thickness of saliva in patients being treated for head and neck cancer. Dornase alfa inhalation solution contains an enzyme that breaks the DNA in mucus into small pieces and makes the mucus thinner. Also called Pulmozyme.
Search NCI's Dictionary of Cancer Terms